Received: 15 May 2020
Accepted: 10 September 2020
First Online: 19 September 2020
Ethics approval and consent to participate
: TRIMECO study is registered with ExternalRef removed, number NCT01148680. TRIMECO study was approved by the French Committee for the Protection of Persons Participating in Biomedical Research (approval number 09-CHUG-21), and clinical trial authorization was obtained from the French National Competent Authority (2008-A01554–51). Written informed consent was obtained from all patients.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
: VFB has received consultancy, lecture fees, or travel support from Alexion Pharmaceuticals, Roche, Apellis. The other authors have no potential conflict of interest.